TINEXTA S.P.A. financials
TINEXTA S.P.A.
815600925CD848EDBA96 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €455.0M | €395.8M |
| Operating expenses | €415.9M | €344.0M |
| Employee benefits expense | €177.9M | €159.5M |
| Raw materials & consumables used | €25.8M | €17.3M |
| Depreciation & amortisation | €54.0M | €39.0M |
| Operating profit (EBIT) | €39.1M | €51.8M |
| Net finance income / (cost) | -€13.8M | -€1.6M |
| Finance costs | €22.7M | €9.4M |
| Profit before tax | €26.6M | €50.0M |
| Income tax expense | €1.7M | €16.2M |
| Profit for the year | €24.9M | €69.4M |
| — attributable to owners | €18.2M | €62.6M |
| — attributable to NCI | €6.6M | €6.8M |
| Total comprehensive income | €22.3M | €65.9M |
| Per share | ||
| Basic EPS | €0.40 | €1.38 |
| Diluted EPS | €0.39 | €1.35 |
| Cash flow statement | ||
| Cash generated from operations | €92.6M | €97.0M |
| Net cash from operating activities | €70.2M | €75.1M |
| Net cash from investing activities | -€123.6M | €65.0M |
| Net cash from financing activities | -€35.8M | -€95.4M |
| Dividends paid | €28.9M | €33.4M |
| Lease liability payments | €7.4M | €5.3M |
| Net change in cash | -€89.2M | €44.7M |
| Balance sheet | ||
| Total assets | €1.17B | €1.02B |
| Non-current assets | €823.0M | €658.8M |
| Property, plant & equipment | €67.3M | €51.2M |
| Intangible assets & goodwill | €725.3M | €545.5M |
| Current assets | €342.0M | €364.4M |
| Inventories | €2.3M | €2.1M |
| Trade & other receivables | €180.2M | €148.3M |
| Cash & equivalents | €72.8M | €161.7M |
| Total equity | €460.6M | €455.0M |
| — attributable to owners | €408.0M | €409.4M |
| Non-controlling interests | €52.6M | €45.6M |
| Non-current liabilities | €355.5M | €254.0M |
| Current liabilities | €349.0M | €314.2M |
| Trade & other payables | €122.9M | €105.2M |
| Deferred tax liabilities | €25.9M | €40.6M |
| Derived metrics | ||
| Operating margin | 8.6% | 13.1% |
| Net margin | 5.5% | 17.5% |
| Return on equity | 5.4% | 15.3% |
| Cash conversion ratio | 2.82× | 1.08× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€570.0K | -€158.0K |
| Adjustments For Depreciation and Amortisation Expense | €54.0M | €39.0M |
| Adjustments For Finance Income Cost | -€13.6M | -€1.8M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €4.9M | €2.5M |
| Adjustments For Income Tax Expense | €1.7M | €15.8M |
| Adjustments For Increase Decrease In Deferred Income Including Contract Liabilities | €4.6M | €14.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | €2.6M | €10.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €141.0K | -€185.0K |
| Adjustments For Provisions | €1.0M | €511.0K |
| Adjustments For Sharebased Payments | €2.1M | €3.8M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €1.3M | -€180.0K |
| Amortisation Assets Recognised From Costs Incurred To Obtain Or Fulfil Contracts With Customers | €12.7M | €6.2M |
| Basic Earnings Loss Per Share From Continuing Operations | €0.40 | €0.59 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.78 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €72.8M | €161.7M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €41.1M |
| Cash Flows From Used In Financing Activities Discontinued Operations | €0 | -€3.0K |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €3.3M | -€5.0K |
| Cash Flows From Used In Investing Activities Discontinued Operations | €0 | €41.1M |
| Cash Flows From Used In Operating Activities Discontinued Operations | €0 | -€2.3M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €103.1M | €16.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | €6.8M | €6.8M |
| Comprehensive Income Attributable To Owners of Parent | €15.5M | €59.1M |
| Current Contract Assets | €50.1M | €22.4M |
| Current Contract Liabilities | €83.1M | €79.0M |
| Current Deferred Income Other Than Current Contract Liabilities | €4.2M | €4.3M |
| Current Derivative Financial Assets | €358.0K | €0 |
| Current Derivative Financial Liabilities | €5.0K | €0 |
| Current Provisions For Employee Benefits | €186.0K | €975.0K |
| Current Tax Assets Current | €8.9M | €1.8M |
| Current Tax Liabilities Current | €3.2M | €2.9M |
| Deferred Tax Assets | €7.5M | €11.9M |
| Diluted Earnings Loss Per Share From Continuing Operations | €0.39 | €0.58 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €0.00 | €0.77 |
| Dividends Recognised As Distributions To Owners Per Share | €0.46 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €292.0K | €98.0K |
| Equity and Liabilities | €1.17B | €1.02B |
| Finance Income | €9.0M | €7.8M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €4.9M | €2.5M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -€1.1M | -€1.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €37.0K | -€150.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €22.4M | €21.9M |
| Increase Decrease Through Acquisition of Subsidiary | €10.0M | — |
| Increase Decrease Through Disposal of Subsidiary | — | -€262.0K |
| Increase Decrease Through Sharebased Payment Transactions | €2.1M | €3.8M |
| Increase Decrease Through Transactions With Owners | -€16.7M | -€12.9M |
| Increase Decrease Through Transfer To Statutory Reserve | — | €0 |
| Increase Decrease Through Transfers and Other Changes Equity | -€518.0K | -€21.0K |
| Interest Paid Classified As Financing Activities | €8.1M | €3.6M |
| Interest Received Classified As Investing Activities | €1.9M | €3.9M |
| Investment Accounted For Using Equity Method | €1.9M | €27.8M |
| Issued Capital | €47.2M | €47.2M |
| Liabilities | €704.4M | €568.2M |
| Miscellaneous Other Operating Expense | €5.3M | €4.3M |
| Noncurrent Contract Liabilities | €19.1M | €17.5M |
| Noncurrent Deferred Income Other Than Noncurrent Contract Liabilities | €595.0K | €863.0K |
| Noncurrent Derivative Financial Assets | €1.3M | €4.5M |
| Noncurrent Derivative Financial Liabilities | €1.5M | €15.0K |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €2.8M | €1.9M |
| Noncurrent Provisions For Employee Benefits | €23.0M | €19.0M |
| Noncurrent Receivables | €3.8M | €4.1M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €1.1M | €1.5M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €93.0K | €0 |
| Other Comprehensive Income | -€2.5M | -€3.5M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€4.5M | -€4.2M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €750.0K | €87.0K |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €20.0K | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €147.0K | -€622.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€2.7M | -€3.1M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €130.0K | -€472.0K |
| Other Current Financial Assets | €21.3M | €26.0M |
| Other Current Financial Liabilities | €134.1M | €121.3M |
| Other Longterm Provisions | €3.4M | €3.2M |
| Other Noncurrent Financial Assets | €3.5M | €1.9M |
| Other Noncurrent Financial Liabilities | €281.9M | €172.9M |
| Other Shortterm Provisions | €1.3M | €539.0K |
| Payments From Changes In Ownership Interests In Subsidiaries | €83.4M | €31.8M |
| Proceeds From Contributions of Noncontrolling Interests | €0 | €30.0M |
| Proceeds From Current Borrowings | €12.0M | €0 |
| Proceeds From Noncurrent Borrowings | €152.2M | €4.5M |
| Proceeds From Sales of Investments Accounted For Using Equity Method | €127.0K | €2.0M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €24.9M | €311.2M |
| Profit Loss From Continuing Operations | €24.9M | €33.8M |
| Profit Loss From Discontinued Operations | €0 | €35.6M |
| Purchase of Financial Instruments Classified As Investing Activities | €4.7M | €211.1M |
| Purchase of Interests In Investments Accounted For Using Equity Method | €0 | €25.8M |
| Purchase of Treasury Shares | — | €3.9M |
| Repayments of Current Borrowings | €10.0M | €0 |
| Repayments of Noncurrent Borrowings | €65.1M | €47.7M |
| Sale Or Issue of Treasury Shares | €4.6M | €815.0K |
| Services Expense | €134.3M | €114.7M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | €0 | €7.0K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €1.3M | -€180.0K |
| Share Premium | €55.4M | €55.4M |
| Treasury Shares | €22.8M | €30.1M |
Every line item above is a fact tagged in TINEXTA S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.